Compare MNKD & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNKD | SBGI |
|---|---|---|
| Founded | 1991 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 998.0M |
| IPO Year | 2004 | 2023 |
| Metric | MNKD | SBGI |
|---|---|---|
| Price | $4.26 | $14.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $8.69 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 4.9M | 508.4K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 6.56% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $348,966,000.00 | ★ $3,169,000,000.00 |
| Revenue This Year | $35.81 | $12.37 |
| Revenue Next Year | $11.89 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $2.23 | $12.46 |
| 52 Week High | $6.51 | $17.88 |
| Indicator | MNKD | SBGI |
|---|---|---|
| Relative Strength Index (RSI) | 57.43 | 51.87 |
| Support Level | $3.74 | $13.13 |
| Resistance Level | $4.55 | $14.81 |
| Average True Range (ATR) | 0.21 | 0.66 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 83.12 | 34.91 |
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.